Metabolic profile and safety of piperlongumine
Piperlongumine (PPL), a natural plant product, has been extensively studied in cancer treatment going up on clinical trials. Since the first report related to its use on cancer research (in 2011) around 80 papers have been published in less than 10 years, but a gap still remaining. There are no meta...
Main Authors: | de Lima Moreira, Fernanda, Habenschus, Maísa D., Barth, Thiago, Marques, Lucas M. M., Pilon, Alan Cesar, da Silva Bolzani, Vanderlan, Vessecchi, Ricardo, Lopes, Norberto P., de Oliveira, Anderson R. M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041077/ |
Similar Items
-
Preformulation Studies on Piperlongumine
by: Aodah, Alhassan, et al.
Published: (2016) -
Piperlongumine induces autophagy by targeting p38 signaling
by: Wang, Y, et al.
Published: (2013) -
Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models
by: Bullova, Petra, et al.
Published: (2016) -
Piperlongumine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane
by: Bissinger, Rosi, et al.
Published: (2014) -
Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
by: Gong, Li-Hua, et al.
Published: (2014)